Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

Lung immune cells can be trained to better fight infections after a virus.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Timely treatment with antibiotics and antiretrovirals can significantly improve health in HIV patients with syphilis.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Enhancing Tregs can protect against alopecia areata.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Chikungunya virus often causes skin issues and inflammation.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.